Brain Training for Schizophrenia
Trial Summary
What is the purpose of this trial?
The primary aim of this study is to provide confirmation that Cognitive Remediation (CR) for schizophrenia, when personalized based on pre-treatment assessment of early auditory processing ability, facilitates improved cognitive and functional outcomes. Additional aims of this study address the mechanisms of treatment effect. The study uses a repeated-measures randomized trial design. Enrollment will be by invitation, open to individuals receiving services at select community behavioral health facilities where CR is offered. Clients who are eligible for the service, who agree to participate in research and who meet inclusion/exclusion criteria will be assessed on outcome measures and categorized via performance on the Tone Matching (TM) test, as EAP impaired (EAP-) or EAP intact (EAP+). Subsequently, EAP- and EAP+ subgroups will be randomized to either (1) Brain Basics (BB; n = 100), an EAP-enhanced CR approach or (2) Brain Training (BT; n = 100), a routine CR approach. Participants will be invited to participate in a second pre-treatment assessment to measure electrophysiologic responses to auditory stimuli. All participants will be scheduled to repeat outcome measure assessments after treatment and after a follow-up period. The EAP- group receiving BB will be invited to repeat electrophysiological paradigms post-treatment to investigate mechanisms of change related to the CR intervention. Verbal learning will be the primary outcome with functional capacity the secondary outcome. EEG is exploratory and will examine neurophysiologic markers of need for and response to EAP training.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be psychiatrically stable, meaning no changes in your psychotropic medication in the last 21 days.
What data supports the effectiveness of the treatment Brain Basics, Brain Training for schizophrenia?
Is brain training for schizophrenia safe for humans?
How does the Brain Training treatment for schizophrenia differ from other treatments?
Brain Training for schizophrenia is unique because it focuses on enhancing brain plasticity (the brain's ability to change and adapt) through intensive cognitive exercises, targeting specific brain areas to improve memory and learning. Unlike traditional treatments, it uses computer-assisted methods to harness neuroplasticity, potentially reversing some of the brain changes associated with schizophrenia.12349
Research Team
Alice Medalia, Ph.D.
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for English-speaking individuals with a primary diagnosis of schizophrenia or schizoaffective disorder who are psychiatrically stable. They should not have had changes in medication or hospitalization in the last 21 days, and no cognitive remediation in the past 24 months, substance dependence within six months, auditory disorders, significant visual impairment, neurological conditions affecting cognition, or an IQ below 70.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including early auditory processing, cognitive ability, and functioning
Treatment
Cognitive Remediation (CR) sessions conducted twice a week for 15 weeks
Post-Treatment Assessment
Participants repeat behavioral assessments and EEG paradigms to explore mechanisms of change
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Brain Basics
- Brain Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator